WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsSpectral AI Inc. (MDAI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 123787% more annual revenue ($20.98B vs $16.93M). GEHC leads profitability with a 9.1% profit margin vs -82.0%. GEHC earns a higher WallStSmart Score of 57/100 (C).

GEHC

Buy

57

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

MDAI

Avoid

17

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 4.7Quality: 5.0
Piotroski: 4/9Altman Z: -4.12
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

MDAIFair Value (-2.7%)

Margin of Safety

-2.7%

Fair Value

$1.50

Current Price

$1.89

$0.39 premium

UndervaluedFair: $1.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC2 strengths · Avg: 8.0/10
P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

MDAI1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.1310/10

Conservative balance sheet, low leverage

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.844/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

EPS GrowthGrowth
-30.9%2/10

Earnings declined 30.9%

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

MDAI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$64.60M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-2308.0%2/10

ROE of -2308.0% — below average capital efficiency

Revenue GrowthGrowth
-40.5%2/10

Revenue declined 40.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio, Price/Book.

Bull Case : MDAI

The strongest argument for MDAI centers on Debt/Equity.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.

Bear Case : MDAI

The primary concerns for MDAI are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

GEHC profiles as a value stock while MDAI is a turnaround play — different risk/reward profiles.

MDAI carries more volatility with a beta of 1.16 — expect wider price swings.

GEHC is growing revenue faster at 7.4% — sustainability is the question.

GEHC generates stronger free cash flow (112M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (57/100 vs 17/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Spectral AI Inc.

HEALTHCARE · MEDICAL DEVICES · USA

Spectral MD Holdings, Ltd., a predictive analytics company, develops AI algorithms and optical technology in wound care treatment. The company is headquartered in Dallas, Texas.

Want to dig deeper into these stocks?